Company Overview and News

Metallica secures Urquhart mining lease

Metallica Minerals has been granted a mining lease for its Urquhart bauxite project in Far North Queensland.

Metallica Minerals eyes bauxite project development following grant of mining lease

Metallica Minerals Limited (ASX:MLM) has achieved another significant milestone as it moves the Urquhart Bauxite Project in Far North Queensland into production.

Crater Gold Mining’s shares rise on drilling graphite from the first hole at Golden Gate

Crater Gold Mining Ltd’s (ASX:CGN) shares are trading circa 11% higher intra-day after intersecting graphite mineralisation from its first drill hole at the Golden Gate Graphite project in Queensland.

Clean TeQ: An In-Depth Analysis

2017-10-18 seekingalpha
The Syerston nickel-cobalt-scandium mining project in Australia boasts one of the largest resource base, highest-grade ores, and lowest-cost of its sort outside of Congo.

Crater Gold fast tracks Croydon graphite drilling

Crater Gold is fast tracking graphite drilling and testing at its Golden Gate project in Croydon, NW Queensland, with a planned start date of late October or early November 2017. The company states that fresh drill core samples are required for metallurgical and mineralogical tests.

Crater Gold Mining to drill Queensland graphite project

Crater Gold Mining (ASX:CGN) plans to fast-track an exploration program with drilling commencing late-October to mid-November at the Golden Gate Graphite Project in Queensland.

Companies To Benefit From The Future Smart Car Boom

2017-08-18 seekingalpha
Electric vehicles are being made with new lightweight materials -- aluminum, scandium, titanium, and the battery materials.

Is A Scandium Boom Next - A Look At The Scandium Miners

2017-08-16 seekingalpha
Scandium demand and supply are hard to really determine at this point; however with the increasing need for light weight aluminum/scandium alloys, scandium demand may soar.

Australian Mines raises funds to advance core cobalt, scandium assets

Australian Mines (ASX:AUZ) has raised circa $4.3 million from investors to fast-track the development of its two core cobalt, scandium assets.

Metallica Minerals’ study supports development of bauxite project

The company’s shares were last trading at $0.053, up 15.22% intraday. Metallica’s PFS estimates pre-tax project net present value of $78.4 million on sales of 6.5 million tonnes of bauxite (proved and probable reserves). The PFS base case points to a potential revenue stream nearing $300 million across 5.5 years of production with a payback period of just five months. The project is expected to generate a strong total operating margin of around $12 per tonne.

Crater Gold Mining Ltd eyes graphite at the Golden Gate Project

Graphite occurrences have been observed along with the gold mineralisation in the region. The rich gold discoveries in 1891 at the Golden Gate reef led to the 1890s being the most productive years for Croydon. In recent times, exploration and development were mainly undertaken by larger companies, focussing on gold, with the large low grade Croydon open pit gold mine operated by Barrack Mines Ltd. Significantly, in May 2016 Metallica Minerals Ltd (ASX:MLM) discovered high purity graphite mineralisation at their Esmeralda Graphite Project located 80 kilometres north of Golden Gate.

Metallica Minerals ships maiden bauxite cargo

The successful barging and transhipment of bauxite ore through the Hey Point facility validates the company’s decision to use the low capital cost and established facility as a logistics solution for the 50% owned Cape York Heavy Metal Sands and Bauxite Project. The Cape York Heavy Metal Sands and Bauxite Project is located 5 kilometres southwest of Weipa and 15 kilometres from the Hey Point facility.

Metallica Minerals gets boost as independent bauxite exports resume

The shipment is the first independent bauxite export from Cape York in more than 50 years. The successful barging and transhipment is significant for Metallica as it plans to export bauxite ore through the same Hey Point facility in 2017. In April 2016, the company entered into an agreement to access the privately owned Hey Point facility to export its sought after high-quality, low-temperature, direct shipping bauxite ore.

Metallica gets $900k from sale

JavaScript disabled. Please enable JavaScript to use My News, My Clippings, My Comments and user settings.

Metallica gets $900k from sale

JavaScript disabled. Please enable JavaScript to use My News, My Clippings, My Comments and user settings.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: Q6016K106